Cargando…
Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations
Randomized controlled trials (RCTs) are regarded as the most reputable source of evidence. In some studies, factors beyond the intervention itself may contribute to the measured effect, an occurrence known as heterogeneity of treatment effect (HTE). If the RCT population differs from the real-world...
Autores principales: | Averitt, Amelia J., Weng, Chunhua, Ryan, Patrick, Perotte, Adler |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214444/ https://www.ncbi.nlm.nih.gov/pubmed/32411828 http://dx.doi.org/10.1038/s41746-020-0277-8 |
Ejemplares similares
-
An OMOP CDM-Based Relational Database of Clinical Research Eligibility Criteria
por: Si, Yuqi, et al.
Publicado: (2017) -
Outcomes of ECLS-SHOCK Eligibility Criteria Applied to a Real-World Cohort
por: von Lewinski, Dirk, et al.
Publicado: (2023) -
A neuro-symbolic method for understanding free-text medical evidence
por: Kang, Tian, et al.
Publicado: (2021) -
How Have Cancer Clinical Trial Eligibility Criteria Evolved Over Time?
por: Yaman, Anil, et al.
Publicado: (2016) -
Characterizing non-heroin opioid overdoses using electronic health records
por: Averitt, Amelia J, et al.
Publicado: (2019)